Original articleLong-term treatment of hereditary angioedema with attenuated androgens: A survey of a 13-year experience☆
References (37)
- et al.
A biochemical abnormality in hereditary angioneurotic edema
Am J Med
(1963) - et al.
CpG mutations in the reactive site of human C1 inhibitor
J Biol Chem
(1989) - et al.
Hereditary angioedema: an appraisal of 104 cases
Am J Med Sci
(1982) - et al.
Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema
J Allergy Clin Immunol
(1980) - et al.
Liver damage from long-term methyltestosterone
Lancet
(1977) - et al.
Morphologic evaluation of the liver in hereditary angioedema patients on long-term treatment with androgen derivatives
J Allergy Clin Immunol
(1983) - et al.
Plasma levels of C1 inhibitor complexes and cleaved C1 inhibitor in patients with hereditary angioneurotic edema
J Clin Invest
(1990) - et al.
Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema
J Clin Invest
(1971) - et al.
Response of variant hereditary angioedema phenotypes to danazol therapy
J Clin Invest
(1979) - et al.
Altered C1 inhibitor genes in type 1 hereditary angioedema
N Engl J Med
(1987)
Restriction fragment length polymorphism of the C1 inhibitor gene in hereditary angioneurotic edema
J Clin Invest
(1987)
Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements
Genetic heterogeneity of hereditary angioneurotic edema
Clin Res
(1987)
Type 1 C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon
J Clin Invest
(1989)
Dysfunctional C1-inhibitor (At), isolated from a type II hereditary-angio-edema plasma, contains a P1 “reactive centre” (Arg444His) mutation
Biochem J
(1988)
Type II hereditary angioneurotic edema may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene
Hereditary angioedema: the clinical syndrome and its management
Ann Intern Med
(1976)
Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities
N Engl J Med
(1976)
Cited by (115)
Miscellaneous Systemic Drugs
2020, Comprehensive Dermatologic Drug Therapy, Fourth EditionFlow-mediated vasodilation assay indicates no endothelial dysfunction in hereditary angioedema patients with C1-inhibitor deficiency
2019, Annals of Allergy, Asthma and ImmunologyProphylactic Therapy for Hereditary Angioedema
2017, Immunology and Allergy Clinics of North AmericaCritical appraisal of androgen use in hereditary angioedema: A systematic review
2015, Annals of Allergy, Asthma and ImmunologyCitation Excerpt :Weight gain appears to be dose related.30 Menstrual changes are among the most common adverse effects among women receiving androgens,13,15,17,20,21,23–25,30,31,33,38,39,41,48,49,52 especially during the first few months of treatment.13,49 Many women cease menstruating after approximately 3 to 15 months of androgen therapy.13,22,49
Hereditary Angioedema in Women. Specific Challenges
2013, Immunology and Allergy Clinics of North AmericaUpdate on Preventive Therapy (Prophylaxis) for Hereditary Angioedema
2013, Immunology and Allergy Clinics of North America
- ☆
Supported in part by the Consiglio Nazionale delle Richerche, Rome, Italy, Grant No. 90.01408.CT04.
- ∗
From the Central Laboratory of The Netherlands Red Cross, Blood Transfusion Service, Amsterdam, The Netherlands.
- ∗∗
From the Clinica Medica, Clinica Ostetrica e Ginecologica, Ospedale S. Paolo, Università di Milano Italy.
Copyright © 1991 Published by Mosby, Inc.